TY  - JOUR
AU  - Duran, I
AU  - Lambea, J
AU  - Maroto, P
AU  - González-Larriba, J L
AU  - Flores, Luis
AU  - Granados-Principal, S
AU  - Graupera, M
AU  - Sáez, B
AU  - Vivancos, A
AU  - Casanovas, O
PY  - 2017
DO  - 10.1007/s11523-016-0463-4
UR  - http://hdl.handle.net/10668/10604
T2  - Targeted oncology
AB  - Renal cell carcinoma (RCC) is a complex disease characterized by mutations in several genes. Loss of function of the von Hippel-Lindau (VHL) tumour suppressor gene is a very common finding in RCC and leads to up-regulation of hypoxia-inducible factor...
LA  - en
KW  - Drug Resistance, Neoplasm
KW  - Humans
KW  - Kidney Neoplasms
TI  - Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action.
TY  - research article
VL  - 12
ER  -